JP Stock MarketDetailed Quotes

4583 Chiome Bioscience

Watchlist
  • 242
  • +8+3.42%
20min DelayTrading Dec 16 15:04 JST
15.11BMarket Cap-9.83P/E (Static)

About Chiome Bioscience Company

Chiome Bioscience Inc is a Japanese based company engaged in the manufacture and sale of antibody drugs through the Autonomous Diversifying Library System. The business activity of the group is operated through Drug Discovery Alliance, Lead Antibody Licensing, and Licensing Out Platform Technology segments. The Drug Discovery Alliance segment partners with pharmaceutical companies to develop and create lead antibody drugs. The Lead Antibody Licensing Out segment is engaged in the production of specific antibodies against antigens and early licensing out to pharmaceutical manufacturers and the Licensing Out Platform Technology segment conducts research and development through the ADLib System. Geographically all the activities are functioned through Japan.

Company Profile

Symbol4583
Company NameChiome Bioscience
Founded2005-02-08
MarketTSE Growth
Fiscal Year Ends12-31
AddressSumitomo Fudosan Nishi-shinjuku Building No.6, 3-12-1 Honmachi, Shibuya-ku
Zip Code151-0071
Phone03-6383-3561

Company Executives

  • Name
  • Position
  • Salary
  • Shigeru Kobayashi
  • Representative Director and President
  • --
  • Zaihiko Bijodaira
  • Director, Corporate Planning Office
  • --
  • Teruyo Taoka
  • Director and Head of Development Headquarters
  • --
  • Masamichi Koike
  • Director, Research Headquarters
  • --
  • Haruhisa Kubota
  • Independent Director
  • --